FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024152074> ?p ?o ?g. }

• W2024152074 endingPage "85" @default.
• W2024152074 startingPage "83" @default.
• W2024152074 abstract "In children with craniopharyngioma, poor growth commonly precedes diagnosis, but is observed less frequently than neurological or visual symptoms. A deficiency of growth hormone (GH) is common before, and almost universal after, treatment of the tumour, and is usually treated with GH. However, a minority of these children with GH deficiency (GHD) grow well without GH replacement therapy but exhibit other metabolic effects of GHD that are correctable by GH treatment. This article provides a review of studies in 422 children with craniopharyngioma whose details have been entered into the database of KIGS, the Kabi International Growth Study. The response to GH during the first year of therapy was similar to that seen in children with idiopathic GHD (IGHD). Leg length was relatively greater than sitting height and this disproportion was maintained during treatment. Adiposity increased in some children receiving GH treatment. At the end of GH treatment in 82 patients, there was a median gain in height SD score of 1.51, with evidence of residual growth potential still remaining in the majority. Tumour recurrence occurred in 13.5% of the total group of patients with craniopharyngioma within KIGS, at a median of 3.9 years from diagnosis and 2.3 years from the start of GH therapy. Tumour recurrence was not associated with an impairment in height achieved, but there was a tendency towards greater adiposity in patients in whom recurrence occurred. Adverse events during GH treatment were more frequent in children with craniopharyngioma than in those with IGHD, and headache was commonly reported. The results of these studies suggest that GH treatment is recommended for the treatment of children with craniopharyngioma on the grounds of improved growth velocity, adult height and other GH-dependent metabolic functions, and of the good safety profile of GH in these patients." @default.
• W2024152074 created "2016-06-24" @default.
• W2024152074 creator A5032844165 @default.
• W2024152074 creator A5055570552 @default.
• W2024152074 date "1996-10-01" @default.
• W2024152074 modified "2023-09-26" @default.
• W2024152074 title "Effect of growth hormone treatment in children with craniopharyngioma with reference to the KIGS (Kabi International Growth Study) database" @default.
• W2024152074 cites W1940095357 @default.
• W2024152074 cites W1999734330 @default.
• W2024152074 cites W2011045152 @default.
• W2024152074 cites W2029551868 @default.
• W2024152074 cites W2044924304 @default.
• W2024152074 cites W4246616666 @default.
• W2024152074 doi "https://doi.org/10.1111/j.1651-2227.1996.tb14307.x" @default.
• W2024152074 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9055921" @default.
• W2024152074 hasPublicationYear "1996" @default.
• W2024152074 type Work @default.
• W2024152074 sameAs 2024152074 @default.
• W2024152074 citedByCount "9" @default.
• W2024152074 countsByYear W20241520742015 @default.
• W2024152074 countsByYear W20241520742016 @default.
• W2024152074 countsByYear W20241520742023 @default.
• W2024152074 crossrefType "journal-article" @default.
• W2024152074 hasAuthorship W2024152074A5032844165 @default.
• W2024152074 hasAuthorship W2024152074A5055570552 @default.
• W2024152074 hasConcept C126322002 @default.
• W2024152074 hasConcept C134018914 @default.
• W2024152074 hasConcept C187212893 @default.
• W2024152074 hasConcept C2777047896 @default.
• W2024152074 hasConcept C2777871287 @default.
• W2024152074 hasConcept C2778135454 @default.
• W2024152074 hasConcept C2779430528 @default.
• W2024152074 hasConcept C2779952775 @default.
• W2024152074 hasConcept C2984496839 @default.
• W2024152074 hasConcept C71315377 @default.
• W2024152074 hasConcept C71924100 @default.
• W2024152074 hasConceptScore W2024152074C126322002 @default.
• W2024152074 hasConceptScore W2024152074C134018914 @default.
• W2024152074 hasConceptScore W2024152074C187212893 @default.
• W2024152074 hasConceptScore W2024152074C2777047896 @default.
• W2024152074 hasConceptScore W2024152074C2777871287 @default.
• W2024152074 hasConceptScore W2024152074C2778135454 @default.
• W2024152074 hasConceptScore W2024152074C2779430528 @default.
• W2024152074 hasConceptScore W2024152074C2779952775 @default.
• W2024152074 hasConceptScore W2024152074C2984496839 @default.
• W2024152074 hasConceptScore W2024152074C71315377 @default.
• W2024152074 hasConceptScore W2024152074C71924100 @default.
• W2024152074 hasIssue "s417" @default.
• W2024152074 hasLocation W20241520741 @default.
• W2024152074 hasLocation W20241520742 @default.
• W2024152074 hasOpenAccess W2024152074 @default.
• W2024152074 hasPrimaryLocation W20241520741 @default.
• W2024152074 hasRelatedWork W2003351700 @default.
• W2024152074 hasRelatedWork W2024152074 @default.
• W2024152074 hasRelatedWork W2043302694 @default.
• W2024152074 hasRelatedWork W2070979653 @default.
• W2024152074 hasRelatedWork W2078765851 @default.
• W2024152074 hasRelatedWork W2309650132 @default.
• W2024152074 hasRelatedWork W2387550679 @default.
• W2024152074 hasRelatedWork W2767426230 @default.
• W2024152074 hasRelatedWork W3183777790 @default.
• W2024152074 hasRelatedWork W3208192604 @default.
• W2024152074 hasVolume "85" @default.
• W2024152074 isParatext "false" @default.
• W2024152074 isRetracted "false" @default.
• W2024152074 magId "2024152074" @default.
• W2024152074 workType "article" @default.